All Asia & Oceania articles – Page 70
-
NewsResearchers propose ultrasonic power therapy for helicobacter pylori infection
Scientists have developed a nanoparticle-based sonodynamic therapy to reduce H. pylori infection in mice without disrupting gut microbiota.
-
NewsProtective human monoclonal antibody targets a conserved site of spike glycoprotein of SARS-CoV-2 Omicron variants
Scientists report that mAb-39 greatly improved the neutralizing activity of anti-RBD antibody, the same type of EUA therapeutic monoclonal antibodies, against the highly neutralization-resistant Omicron variants.
-
NewsResearchers reveal molecular mechanism of CsMLO8/11 in regulating cucumber powdery mildew resistance
Scientists have made important progress in uncovering the molecular mechanism of powdery mildew (PM) resistance in cucumber.
-
NewsIVI to open Africa Regional Office in Rwanda
The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and the Ministry of Health of Rwanda have announced that IVI will open its Africa Regional Office in Kigali this year. The IVI ...
-
News‘Artificial tongue’ detects and inactivates common mouth bacteria
Researchers have designed a chemical sensor array, or an artificial tongue, that distinguishes dental bacteria and can inactivate them.
-
NewsLow-temperature plasma used to remove E. coli from hydroponically grown crops
A group led by researchers at Nagoya University and Meijo University in Japan has developed a disinfection technology that uses low-temperature plasma generated by electricity to cultivate environmentally friendly hydroponically grown crops. This innovative technology sterilizes the crops, promoting plant growth without the use of chemical fertilizers. Their findings appear ...
-
NewsFusion protein reveals a conservative antigenic domain across herpesviruses
A new study proposes that the gB DII domain within the herpesvirus family constitutes a broadly conserved neutralizing epitope structural domain.
-
NewsBlindness from some inherited eye diseases may be caused by gut bacteria
Sight loss in certain inherited eye diseases may be caused by gut bacteria, and is potentially treatable by antimicrobials, finds a new study in mice co-led by a UCL and Moorfields researcher. The international study observed that in eyes with sight loss caused by a particular genetic ...
-
NewsBiomineralization offers sustainable strategy against microbial corrosion in marine concrete
Researchers have introduced a novel biomineralization strategy, which effectively isolates marine concrete from microbially induced corrosion, contributing to the achievement of sustainable coastal structures.
-
NewsSK bioscience’s typhoid conjugate vaccine achieves WHO prequalification
SK bioscience and the International Vaccine Institute (IVI) announced that the typhoid conjugate vaccine developed by SK bioscience with technology transfer from IVI has achieved the World Health Organization prequalification (PQ).
-
NewsGut microbes may cause some COVID-19 patients to have higher blood clot risk
A gut microbial metabolite called 2-methylbutyrylcarnitine (2MBC) plays a role in exacerbating thrombosis – the formation of blood clots – and is accumulated in individuals with COVID-19.
-
NewsHigh resolution techniques reveal clues to early microbes in 3.5 billion-year-old biomass
A research team has found new clues about the formation and composition of the 3.5bn year old rocks of Pilbara Craton, which contain traces of the microorganisms that lived at that time.
-
NewsStudy examines medical mystery of child hepatitis outbreak
A study into an unexpected wave of severe hepatitis cases in 2022 supports the theory that it was caused by an infection of different viruses at the same time, but also reveals cases were higher and more severe than initially thought.
-
NewsResearchers develop molecules for a new class of antibiotics that can overcome drug resistant bacteria
A new class of antibiotics not only shows promise against a broad array of bacterial infections but can also evade the dreaded resistance that has been rendering our current generation of first-line antibiotics ineffective.
-
NewsScientists craft enhanced viral structure in VLP vaccines through polymer restructuring
Researchers reported a viromimetic polymer nanoparticle vaccine (VPNVax), crafted by rearranging the RBD proteins of the coronavirus and modifying them onto the surface of pre-assembled polyethylene glycol-polylactic acid polymer nanoparticles.
-
NewsScientists reveal what makes ‘bad’ bacteria life-threatening
Researchers have discovered that a mutation allows some E. coli bacteria to cause severe disease in people while other bacteria are harmless, a finding that could help to combat antibiotic resistance.
-
NewsPhotosynthetic mechanism of purple sulfur bacterium adapted to low-calcium environments revealed
Researchers revealed the LH1-RC structures of Allochromatium vinosum, a model species of autotrophic bacteria capable of thriving in low-calcium or soft-water environments, at a resolution that enabled individual amino acid visualization.
-
NewsPlasma device is giant step forward to help treat chronic wounds that affect millions
A team of international scientists has developed a more effective treatment for chronic wounds that does not involve antibiotics or silver-based dressings, but an ionized gas called plasma. Source: University of South Australia The plasma activates oxygen and nitrogen molecules to treat wounds effectively. The treatment involves ...
-
NewsPD-1-enhanced DNA vaccine achieves 6-year cART-free AIDS prevention and virologic control
Researchers have found that PD-1-enhanced DNA vaccination can induce sustained virus-specific CD8+ T cell immunity in an AIDS monkey model.
-
NewsResearch reveals how lenacapavir pushes HIV capsid to breaking point
Researchers have uncovered the details of how the novel drug lenacapavir works to stop the virus in its tracks. The molecular mechanisms that they uncovered could help to refine and design more effective anti-viral therapies.